Treatment Outcomes of Slow Coagulation Transscleral Cyclophotocoagulation for Medically Uncontrolled Glaucoma in Korean Patients.
Hwang Young Hoon, Lee Sharon, Kim Mijin, Choi Jaewan
AI Summary
SC-CPC effectively lowered eye pressure and medication use in Korean patients with uncontrolled glaucoma, showing promise as a useful treatment option despite some visual decline.
Abstract
Précis: Slow coagulation transscleral cyclophotocoagulation showed useful intraocular pressure control in Korean patients with medically uncontrolled glaucoma.
Purpose
This study aimed to evaluate the treatment outcomes of slow coagulation transscleral cyclophotocoagulation (SC-CPC) in Korean patients with medically uncontrolled glaucoma.
Methods
Medical records of 95 eyes from 95 patients who underwent SC-CPC to control intraocular pressure (IOP) were reviewed. Success was defined as an IOP of 6-21 mmHg with a ≥20% reduction from baseline, and no additional incisional surgery for glaucoma. Visual acuity presented as logarithm of the minimum angle of resolution (logMAR), the number of glaucoma medications, corneal endothelial cell count, and complications were analyzed.
Results
At 12 months postoperatively, mean IOP decreased from 32.7±13.8 mmHg to 16.2±9.4 mmHg (P<0.001) and the mean number of medications decreased from 2.6±0.9 to 2.0±1.0 (P<0.001). Mean visual acuity declined from 0.69±0.94 to 0.80±0.99 logMAR (P=0.015). No significant changes were found in corneal endothelial cell counts at any postoperative visits (P>0.05). Eighteen eyes (18.9%) underwent repeated SC-CPC treatments. The most common complication was transient hypotony (4.2%), followed by macular edema (3.2%), prolonged hypotony (1.1%), and corneal decompensation (1.1%). The 12-month success rate was 57.1%.
Conclusion
SC-CPC is a useful method for IOP control in Korean patients with medically uncontrolled glaucoma.
Shields Classification
Key Concepts5
In Korean patients with medically uncontrolled glaucoma (95 eyes from 95 patients), slow coagulation transscleral cyclophotocoagulation (SC-CPC) decreased mean intraocular pressure (IOP) from 32.7±13.8 mmHg to 16.2±9.4 mmHg at 12 months postoperatively (P<0.001).
In Korean patients with medically uncontrolled glaucoma (95 eyes from 95 patients), slow coagulation transscleral cyclophotocoagulation (SC-CPC) decreased the mean number of glaucoma medications from 2.6±0.9 to 2.0±1.0 at 12 months postoperatively (P<0.001).
In Korean patients with medically uncontrolled glaucoma (95 eyes from 95 patients) undergoing slow coagulation transscleral cyclophotocoagulation (SC-CPC), mean visual acuity declined from 0.69±0.94 to 0.80±0.99 logMAR at 12 months postoperatively (P=0.015).
The 12-month success rate for slow coagulation transscleral cyclophotocoagulation (SC-CPC) in Korean patients with medically uncontrolled glaucoma (95 eyes from 95 patients) was 57.1%, defined as an IOP of 6-21 mmHg with a ≥20% reduction from baseline and no additional incisional surgery for glaucoma.
The most common complication of slow coagulation transscleral cyclophotocoagulation (SC-CPC) in Korean patients with medically uncontrolled glaucoma (95 eyes from 95 patients) was transient hypotony (4.2%), followed by macular edema (3.2%), prolonged hypotony (1.1%), and corneal decompensation (1.1%).
Related Articles5
Ultrasound ciliary plasty in glaucoma treatment: A long-term follow-up study.
Cohort StudyDirect Costs of Second Aqueous Shunt Implant Versus Transscleral Cyclophotocoagulation (The Assists Trial).
Randomized Controlled TrialComparative efficacy and safety of micropulse transscleral laser cyclophotocoagulation using different duration protocols in eyes with good visual acuity.
Retrospective StudiesOutcomes of Micropulse Transscleral Cyclophotocoagulation in Eyes With Good Central Vision.
Retrospective StudiesMP3 Plus: A Modified Micropulse Transscleral Cyclophototherapy Technique for the Treatment of Refractory Glaucoma.
Case SeriesIs this article assigned to the wrong chapter(s)? Let us know.